Results for tag: "Renflexis"

Renflexis is a biologic drug used to treat immune disorders, such as rheumatoid arthritis, Crohn's disease, and ulcerative colitis. It is a biosimilar to Remicade, a monoclonal antibody that works by blocking the action of tumor necrosis factor (TNF), a protein that plays a role in inflammation. Renflexis is administered intravenously and is designed to provide the same efficacy and safety as Remicade. Renflexis is part of a growing market of immune disorder drugs, which includes other biologics, such as Humira, Enbrel, and Orencia, as well as small molecule drugs, such as methotrexate and sulfasalazine. These drugs are used to treat a variety of immune disorders, including psoriasis, ankylosing spondylitis, and juvenile idiopathic arthritis. The companies in the Renflexis market include Merck, Pfizer, AbbVie, Janssen, and Samsung Bioepis. Show Less Read more